NDC 0641-6217-01 - ROBAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6217
- Requested NDC
- 0641-6217-01
- Package NDCs from labels
- 0641-6217-01, 0641-6217-10, 0641-6217-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBAXIN Injectable (methocarbamol injection, USP) | Hikma Pharmaceuticals USA Inc. | 2024-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6217-01 | ROBAXIN | 10 mL in 1 VIAL | INJECTION | 10 | 7 | |
| 0641-6217-10 | ROBAXIN | 10 in 1 CARTON | INJECTION | 10 | 7 | |
| 0641-6217-25 | ROBAXIN | 25 in 1 CARTON | INJECTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6217-01 | ML - Milliliter | 0641-6217 | 2438936d-92e9-4049-b7e6-e5cd29d24ec4 | 1 | 2018-04-19 |
| 0641-6217-10 | ML - Milliliter | 0641-6217 | 6b59dbca-486a-44fe-873d-0de61865480a | 1 | 2024-05-16 |
| 0641-6217-25 | ML - Milliliter | 0641-6217 | 62677966-065d-4f14-b2de-140ea2a4e67e | 1 | 2018-04-19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 46e983de-434e-7ff3-e063-6394a90aa466 | 2025-12-27 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 18810520-3040-4802-e063-6294a90a1ec0 | 2025-12-03 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 7f297ac6-a580-4539-a770-fe5d15c2b922 | 2025-11-24 | Warnings, Adverse reactions | 125OD7737X |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2025-11-21 | Warnings, Adverse reactions | 125OD7737X |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | Oncora Pharma, LLC | 440d6c99-8aca-af07-e063-6294a90aee3d | 2025-11-20 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 39bc9ecf-837e-5bb8-e063-6394a90a917e | 2025-11-13 | Warnings, Adverse reactions | 125OD7737X |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.